Evidence map›Paper›PMID 30740360›Full record

ArticleFrontiers in oncology2019

Scorpion Venom Analgesic Peptide, BmK AGAP Inhibits Stemness, and Epithelial-Mesenchymal Transition by Down-Regulating PTX3 in Breast Cancer.

Sylvanus Kampo, Bulbul Ahmmed, Tingting Zhou, Lawrence Owusu, Thomas Winsum Anabah, Natacha Raissa Doudou, Eugene Dogkotenge Kuugbee, Yong Cui, Zhili Lu, Qiu Yan and 1 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 55 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Sylvanus KampoDepartment of Anesthesiology, Dalian Medical University, Dalian, China.
Bulbul AhmmedDepartment of Biochemistry and Molecular Biology, Dalian Medical University, Dalian, China.
Tingting ZhouDepartment of Anesthesiology, Dalian Medical University, Dalian, China.
Lawrence OwusuDepartment of Biotechnology, Dalian Medical University, Dalian, China.
Thomas Winsum AnabahDepartment of Anesthesia and Intensive Care, School of Medicine and Health Science, University for Development Studies, Tamale, Ghana.
Natacha Raissa DoudouDepartment of Radiology, Dalian Medical University, Dalian, China.
Eugene Dogkotenge KuugbeeDepartment of Clinical Microbiology, School of Medicine and Health Science, University for Development Studies, Tamale, Ghana.
Yong CuiSchool of Life Science and Bio-pharmaceutics, Shenyang Pharmaceutical University, Shenyang, China.
Zhili LuDepartment of Ophthalmology, First Affiliated Hospital of Dalian Medical University, Dalian, China.
Qiu YanDepartment of Biochemistry and Molecular Biology, Dalian Medical University, Dalian, China.
Qing-Ping WenDepartment of Anesthesiology, Dalian Medical University, Dalian, China.
Dalian Medical University · CNFirst Affiliated Hospital of Dalian Medical University · CNUniversity for Development Studies · GHShenyang Pharmaceutical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A scorpion peptide reported to exhibit both analgesic and antitumor activity in animal models may present as an alternative therapeutic agent for breast cancer. We aimed to investigate the effect of

Indexed as

breast cancerepithelial-mesenchymal transitionpentraxin 3rBmK AGAPscorpion venom analgesic peptidestemnesstranscription factor NF-κBWnt/β-catenin signaling

Identifiers

PMID30740360
PMCPMC6355678
OpenAlexW2913659774

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.